Influence of vindesine exposure on the micronucleus formation and cell survival in V79 cells
Author:
Publisher
Elsevier BV
Subject
Health, Toxicology and Mutagenesis,Genetics,Molecular Biology
Reference50 articles.
1. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and Hodgkin's disease absence of cross resistance with vincristine;Mathe;Cancer Treat. Rep.,1978
2. Vindesine in the treatment of squamous cell carcinoma (WHO I) adenocarcinoma (WHO II) and large cell carcinoma (WHO IV) of the lung;Ferrazi;Tumori,1982
3. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine;Garewal;J. Clin. Oncol.,1983
4. Vindesine therapy melphalan resistant multiple myeloma;Houwen;Eur. J. Cancer,1981
5. An initial report of a phase III trial comparing vindesine and vincristine for acute leukemia of childhood;Krivit;Cancer Chemother. Pharmacol.,1979
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Determination of Antineoplastic Activity of Rohituka, Aphanamixis Polystachya (Wall) RN Parker in Hela Cells: Correlation with Clonogenicity and DNA Damage;International Journal of Complementary & Alternative Medicine;2016-04-19
2. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins;Mutation Research/Genetic Toxicology and Environmental Mutagenesis;2011-03
3. Química e farmacologia de quimioterápicos antineoplásicos derivados de plantas;Química Nova;2010
4. Ecotoxicological Evaluation in an Effluent and Petrochemical Waste Disposal Area;Water, Air, and Soil Pollution;2009-01-16
5. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival;Journal of Applied Toxicology;2007
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3